Identification of estrogen-responsive genes by complementary deoxyribonucleic acid microarray and characterization of a novel early estrogen-induced gene:: EEIG1

被引:123
作者
Wang, DY
Fulthorpe, R
Liss, SN
Edwards, EA
机构
[1] Univ Toronto, Dept Chem Engn & Appl Chem, Toronto, ON M5S 3E5, Canada
[2] Univ Toronto, Banting & Best Dept Med Res, Toronto, ON M5S 3E5, Canada
[3] Univ Toronto, Dept Phys & Environm Sci, Scarborough, ON M1C 1A4, Canada
[4] Ryerson Univ, Dept Chem Biol & Chem Engn, Toronto, ON M5B 2K3, Canada
关键词
D O I
10.1210/me.2003-0202
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Estrogen receptors (ERs) are nuclear transcription factors that regulate gene expression in response to estrogen and estrogen-like compounds. Identification of estrogen-regulated genes in target cells is an essential step toward understanding the molecular mechanisms of estrogen action. Using cDNA microarray examinations, 19 genes were identified as induced by 17beta-estradiol in MCF-7 cells, 10 of which have been reported previously to be estrogen responsive or to be linked with ER status. Five known estrogen-regulated genes, E2IG4, IGFBP4, SLC2A1, XBP1 and B4GALT1, and AFG3L1, responded quickly to estrogen treatment. A novel estrogen-responsive gene was identified and named EEIG1 for early estrogen-induced gene 1. EEIG1 was clearly induced by 17beta-estradiol within 2 h of treatment, and was widely responsive to a group of estrogenic compounds including natural and synthetic estrogens and estrogenic environmental compounds. EEIG1 was expressed in ER-positive but not in ER-negative breast cancer cell lines. EEIG1 expression was repressed by antiestrogens 4-OH-tamoxifen and ICI 182,780 but not by protein synthesis inhibitors cycloheximide and puromycin. These results provide evidence that some estrogenic compounds differentially enhance the transcription of estrogen-regulated genes and suggest a role for EEIG1 in estrogen action.
引用
收藏
页码:402 / 411
页数:10
相关论文
共 30 条
[1]
Endocrine-responsive breast cancer and strategies for combating resistance [J].
Ali, S ;
Coombes, RC .
NATURE REVIEWS CANCER, 2002, 2 (02) :101-+
[2]
17α-estradiol-induced VEGF-A expression in rat pituitary tumor cells is mediated through ER independent but PI3K-Akt dependent signaling pathway [J].
Banerjee, S ;
Saxena, N ;
Sengupta, K ;
Banerjee, SK .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2003, 300 (01) :209-215
[3]
Bouras T, 2002, CANCER RES, V62, P1289
[4]
Charpentier AH, 2000, CANCER RES, V60, P5977
[5]
Estrogen augments glucose transporter and IGF1 expression in primate cerebral cortex [J].
Cheng, CM ;
Cohen, M ;
Wang, J ;
Bondy, CA .
FASEB JOURNAL, 2001, 15 (06) :907-915
[6]
Mechanisms of disease - Estrogen and the risk of breast cancer [J].
Clemons, M ;
Goss, P .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (04) :276-285
[7]
Custodia N, 2001, ANN NY ACAD SCI, V948, P32
[8]
Fan SJ, 2000, CANCER RES, V60, P5635
[9]
RERG is a novel ras-related, estrogen-regulated and growth-inhibitory gene in breast cancer [J].
Finlin, BS ;
Gau, CL ;
Murphy, GA ;
Shao, HP ;
Kimel, T ;
Seitz, RS ;
Chiu, YF ;
Botstein, D ;
Brown, PO ;
Tamanoi, F ;
Andres, DA ;
Perou, CM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (45) :42259-42267
[10]
Nitrogen fixation - Endocrine disrupters and flavonoid signalling [J].
Fox, JE ;
Starcevic, M ;
Kow, KY ;
Burow, ME ;
McLachlan, JA .
NATURE, 2001, 413 (6852) :128-129